International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 3 , Pages 639-648 , 1 November 2009

Erectile Function Durability Following Permanent Prostate Brachytherapy

  • Al V. Taira, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Washington, Seattle, WA
    • ,
  • Gregory S. Merrick, M.D.

      Affiliations

    • Schiffler Cancer Center, Wheeling Jesuit University, Wheeling, West Virginia
    • Corresponding Author InformationAddress reprint requests to: Gregory S. Merrick, M.D., Schiffler Cancer Center, Wheeling Hospital, 1 Medical Park, Wheeling WV 26003-6300. Tel: (304) 243-3490; Fax: (304) 243-5047
    • ,
  • Robert W. Galbreath, Ph.D.

      Affiliations

    • Schiffler Cancer Center, Wheeling Jesuit University, Wheeling, West Virginia
    • ,
  • Wayne M. Butler, Ph.D.

      Affiliations

    • Schiffler Cancer Center, Wheeling Jesuit University, Wheeling, West Virginia
    • ,
  • Kent E. Wallner, M.D.

      Affiliations

    • Puget Sound Healthcare Corporation, Group Health Cooperative, University of Washington, Seattle, WA
    • ,
  • Brian S. Kurko, C.M.D., M.S.

      Affiliations

    • Schiffler Cancer Center, Wheeling Jesuit University, Wheeling, West Virginia
    • ,
  • Richard Anderson, R.T.T.

      Affiliations

    • Schiffler Cancer Center, Wheeling Jesuit University, Wheeling, West Virginia
    • ,
  • Jonathan H. Lief, Ph.D.

      Affiliations

    • Schiffler Cancer Center, Wheeling Jesuit University, Wheeling, West Virginia

Received 8 September 2008 ,Revised 14 November 2008 ,Accepted 18 November 2008.

References 

  1. Wilt TJ, MacDonald R, Rutks I, et al. Systematic review: Comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med. 2008;148:435–448
  2. Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358:1250–1261
  3. Talcott JA, Manola J, Clark JA, et al. Time course and predictors of symptoms after primary prostate cancer therapy. J Clin Oncol. 2003;21:3979–3986
  4. Robinson JW, Moritz S, Fung T. Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma. Int J Radiat Oncol Biol Phys. 2002;54:1063–1068
  5. Merrick GS, Butler WM, Wallner KE, et al. Erectile function after prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2005;62:437–447
  6. Stock RG, Kao J, Stone NN. Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer. J Urol. 2001;165:436–439
  7. Rosen RC, Riley A, Wagner G, et al. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822–830
  8. Wallner K, Merrick G, True L, et al. 125I versus 103Pd for low-risk prostate cancer: preliminary PSA outcomes from a prospective randomized multicenter trial. Int J Radiat Oncol Biol Phys. 2003;57:1297–1303
  9. Wallner K, Merrick G, True L, et al. 20 Gy versus 44 Gy supplemental beam radiation with Pd-103 prostate brachytherapy: Preliminary biochemical outcomes from a prospective randomized multi-center trial. Radiother Oncol. 2005;75:307–310
  10. Merrick GS, Wallner K, Butler WM, et al. A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction. Int J Radiat Oncol Biol Phys. 2001;50:597–604
  11. Wallner KE, Merrick GS, Benson ML, et al. Penile bulb imaging. Int J Radiat Oncol Biol Phys. 2002;53:928–933
  12. Dubbelman YD, Dohle GR, Schroder FH. Sexual function before and after radical retropubic prostatectomy: A systematic review of prognostic indicators for a successful outcome. Eur Urol. 2006;50:711–718discussion 718–720
  13. Mulhall J, Ahmed A, Parker M, et al. The hemodynamics of erectile dysfunction following external beam radiation for prostate cancer. J Sex Med. 2005;2:432–437
  14. Zelefsky MJ, Eid JF. Elucidating the etiology of erectile dysfunction after definitive therapy for prostatic cancer. Int J Radiat Oncol Biol Phys. 1998;40:129–133
  15. Montorsi F, Briganti A, Salonia A, et al. Current and future strategies for preventing and managing erectile dysfunction following radical prostatectomy. Eur Urol. 2004;45:123–133
  16. Kiteley RA, Lee WR, deGuzman AF, et al. Radiation dose to the neurovascular bundles or penile bulb does not predict erectile dysfunction after prostate brachytherapy. Brachytherapy. 2002;1:90–94
  17. Merrick GS, Butler WM, Dorsey AT, et al. A comparison of radiation dose to the neurovascular bundles in men with and without prostate brachytherapy-induced erectile dysfunction. Int J Radiat Oncol Biol Phys. 2000;48:1069–1074
  18. Wright JL, Newhouse JH, Laguna JL, et al. Localization of neurovascular bundles on pelvic CT and evaluation of radiation dose to structures putatively involved in erectile dysfunction after prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2004;59:426–435
  19. Mangar SA, Sydes MR, Tucker HL, et al. Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: Using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397). Radiother Oncol. 2006;80:355–362
  20. Merrick GS, Butler WM, Wallner KE, et al. The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction. Int J Radiat Oncol Biol Phys. 2002;54:1055–1062
  21. Roach M, Winter K, Michalski JM, et al. Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: Findings from a prospective, multi-institutional, phase I/II dose-escalation study. Int J Radiat Oncol Biol Phys. 2004;60:1351–1356
  22. Macdonald AG, Keyes M, Kruk A, et al. Predictive factors for erectile dysfunction in men with prostate cancer after brachytherapy: Is dose to the penile bulb important?. Int J Radiat Oncol Biol Phys. 2005;63:155–163
  23. van der Wielen GJ, Hoogeman MS, Dohle GR, et al. Dose-volume parameters of the corpora cavernosa do not correlate with erectile dysfunction after external beam radiotherapy for prostate cancer: Results from a dose-escalation trial. Int J Radiat Oncol Biol Phys. 2008;71:795–800
  24. Selek U, Cheung R, Lii M, et al. Erectile dysfunction and radiation dose to penile base structures: A lack of correlation. Int J Radiat Oncol Biol Phys. 2004;59:1039–1046
  25. Schwartz EJ, Wong P, Graydon RJ. Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol. 2004;171:771–774
  26. McCullough AR, Levine LA, Padma-Nathan H. Return of nocturnal erections and erectile function after bilateral nerve-sparing radical prostatectomy in men treated nightly with sildenafil citrate: Subanalysis of a longitudinal randomized double-blind placebo-controlled trial. J Sex Med. 2008;5:476–484
  27. Bannowsky A, Schulze H, van der Horst C, et al. Recovery of erectile function after nerve-sparing radical prostatectomy: Improvement with nightly low-dose sildenafil. BJU Int. 2008;101:1279–1283
  28. Padma-Nathan E, McCullough A, Giuliano F. Postoperative nightly administration of sildenafil citrate significantly improves he return of spontaneous erectile function after bilateral nerve-sparing radical prostatectomy. J Urol. 2003;4:375
  29. Merrick GS, Taubenslag W, Andreini H, et al. The morbidity of transperineal template-guided prostate mapping biopsy. BJU Int. 2008;101:1524–1529
  30. Cesaretti JA, Kao J, Stone NN, et al. Effect of low dose-rate prostate brachytherapy on the sexual health of men with optimal sexual function before treatment: Analysis at > or = 7 years of follow-up. BJU Int. 2007;100:362–367

 Conflict of interest: none.

PII: S0360-3016(08)03828-5

doi: 10.1016/j.ijrobp.2008.11.058

International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 3 , Pages 639-648 , 1 November 2009

Article Tools

* Image Usage & Resolution